Cite
HARVARD Citation
Reich, K. et al. (2017). Sustained response with ixekizumab treatment of moderate-to-severe psoriasis with scalp involvement: results from three phase 3 trials (UNCOVER-1, UNCOVER-2, UNCOVER-3). Journal of dermatological treatment. pp. 282-287. [Online].